based on interaction of insoluble-lipophilic molecule with polymers resulting in a solid composition. When in aqueous media the lipophilic compound dissolves faster and to a higher extent, enhancing the drug bioavailability
Sublingual composition that provides better permeability of insoluble drugs through oral mucosa and faster onset of action
Powdered composition for intranasal delivery comprised of uniform spherical API and a carrier approved for inhalations. The active compound’s shape, size and morphology in combination with a device provides a precise delivery of the drug to the upper nose and brain via olfactory bulb thus bypassing the BBB.